HIF-PH Encoded by EGLN1 Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia.
Guo W, Liang D, Wang P, Yin L, Zhang H, Xing C, Huang Z, Wu Y, Li H, Cheng Z, Xiao X, Liu J, Wang Z, Peng H.
Guo W, et al. Among authors: wang z, wang p.
Pharmaceuticals (Basel). 2022 Jun 10;15(6):734. doi: 10.3390/ph15060734.
Pharmaceuticals (Basel). 2022.
PMID: 35745653
Free PMC article.